SUPRIYA LIFESCIENCE
Back to Balance Sheet
|
SUPRIYA LIFESCIENCE Last 5 Year Total Liabilities History
[Standalone]
Mar2024 | Mar2023 | Mar2022 | Mar2021 | Mar2020 | |
---|---|---|---|---|---|
Total Liabilities | ₹924 Cr | ₹820 Cr | ₹735 Cr | ₹445 Cr | ₹336 Cr |
What is the latest Total Liabilities ratio of SUPRIYA LIFESCIENCE ?
Year | Total Liabilities |
---|---|
Mar2024 | ₹924 Cr |
Mar2023 | ₹820 Cr |
Mar2022 | ₹735 Cr |
Mar2021 | ₹445 Cr |
Mar2020 | ₹336 Cr |
How is Total Liabilities of SUPRIYA LIFESCIENCE Trending?
Years | Total Liabilities | % Change | |
---|---|---|---|
Mar2024 | ₹924 Cr | 12.63 | |
Mar2023 | ₹820 Cr | 11.64 | |
Mar2022 | ₹735 Cr | 64.94 | |
Mar2021 | ₹445 Cr | 32.41 | |
Mar2020 | ₹336 Cr | - |
Compare Total Liabilities of peers of SUPRIYA LIFESCIENCE
Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
SUPRIYA LIFESCIENCE | ₹5,297.7 Cr | -1.4% | -7.8% | 59.3% | Stock Analytics | |
SUN PHARMACEUTICAL INDUSTRIES | ₹391,607.0 Cr | -5.9% | -2.8% | -5.3% | Stock Analytics | |
DIVIS LABORATORIES | ₹170,148.0 Cr | -3.7% | -6.9% | 30.1% | Stock Analytics | |
TORRENT PHARMACEUTICALS | ₹121,471.0 Cr | -3.8% | 7.1% | 12% | Stock Analytics | |
CIPLA | ₹121,103.0 Cr | -3.9% | -0.8% | -0.9% | Stock Analytics | |
DR REDDYS LABORATORIES | ₹101,306.0 Cr | -6% | -7.3% | -12% | Stock Analytics |
SUPRIYA LIFESCIENCE Share Price vs Sensex
Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
SUPRIYA LIFESCIENCE | -1.4% |
-7.8% |
59.3% |
SENSEX | -0.8% |
-3.3% |
-1.4% |
You may also like the below Video Courses